Drugs / doxorubicon
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01495884 | Mar 2011 → Oct 2014 | HER2 positive breast carcinoma | Cancer Trials Ireland | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | doxorubicon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01495884 ↗ |
| Known as | Myocet | “non-pegylated liposomal doxorubicon (Myocet™)” NCT01495884 ↗ |